Health China
Seventh International Symposium on Melanoma and Other Cutaneous Malignancies
Jumeirah Essex House
160 Central Park South
New York City, New York
Seventh International Symposium on Melanoma and Other Cutaneous Malignancies

Schedule of Presentations:

Friday, March 12, 2010
07:30:00 Registration and Continental Breakfast
08:00:00 Welcome and Introductions Sanjiv S. Agarwala
08:05:00 Session 1: Melanoma Prevention, Surveillance, and Diagnosis Allan Halpern
08:05:00 Presession Survey
08:10:00 Prevention and Risk: An Update
08:30:00 Current Diagnostic Tools Ashfaq A. Marghoob
08:50:00 New Technologies on the Horizon Allan Halpern
09:10:00 Panel Discussion
09:30:00 Break
09:35:00 Session 2: Clinical and Molecular Markers in Melanoma Sanjiv S. Agarwala
09:45:00 The Genetics of Melanoma Hensin Tsao
10:15:00 Moving Toward Personalized Therapy: Predictive Biomarkers for IFN, IL-2, DTIC/TMZ, and CTLA-4 Therapies
10:45:00 Postsession Survey/Panel Discussion
11:05:00 Break
11:10:00 Session 3: Surgery and Adjuvant Therapy Vernon K. Sondak
11:15:00 Presession Survey
11:20:00 Sentinel Lymph Node Biopsy: Status in 2010 Vernon K. Sondak
11:40:00 Adjuvant Therapy: Do We Have a New Standard? Alexander Eggermont
12:00:00 Break
12:05:00 Working Lunch
12:15:00 Interactive Diagnostic Workshop
13:30:00 Break
13:35:00 Session 4: Approaching Advanced Melanoma Sanjiv S. Agarwala
13:45:00 Presession Survey
13:50:00 A Phase II Trial of Chemoablation: An Update
14:10:00 Pulling the Apoptosis Trigger
14:30:00 Molecular Markers in Melanoma: Therapeutic Implications Mohammed Kashani-Sabet
14:50:00 Panel Discussion
15:15:00 Break
15:20:00 Session 5: Melanoma at Specific Anatomic Sites Allan Halpern
15:30:00 Targeted Therapies for Mucosal, Acral, and Uveal Melanoma: An Update Donald P. Lawrence
15:50:00 Targeting the Liver: Percutaneous Hepatic Perfusion/Intra-Arterial James , Pingpank
16:10:00 Managing Patients With Brain Metastases Wolfram Samlowski
16:30:00 Postsession Survey/Panel Discussion
16:50:00 Break
16:55:00 Session 6: Poster Presentations and Discussion (Non-CME)
17:00:00 Reception and Poster Presentations
17:45:00 Poster Discussion
18:00:00 Adjourn
Saturday, March 13, 2010
07:30:00 Continental Breakfast
08:00:00 Welcome and Introductions Sanjiv S. Agarwala
08:05:00 Session 7: CTCL and Other Cutaneous Malignancies Francine Foss
08:05:00 Presession Survey
08:10:00 Immune-Based Therapy in CTCL: When Should It Be Used? Francine Foss
08:30:00 Epigenetics and CTCL Therapy Steven Horwitz
08:50:00 Merkel Cell Carcinoma in 2010
09:10:00 Panel Discussion
09:30:00 Postsession Survey
09:35:00 Break
09:40:00 Session 8: Novel Agents: Update on Recent and Current Trials Keith Flaherty
09:50:00 The B-Raf Pathway in Melanoma: Is This the Therapeutic Target We Have Been Looking For? Keith Flaherty
10:10:00 Antiangiogenic Agents in Melanoma: Update on the BEAM Trial Steven O’Day
10:30:00 GM-CSF as Adjuvant Therapy: Update on E4697 David Lawson
10:50:00 Results of the AGENDA Trial: Does LDH Matter? Sanjiv S. Agarwala
11:10:00 Microtubule Inhibitors in Melanoma: Current Status Axel Hauschild
11:30:00 Is the Carboplatin/Paclitaxel Combination the New Standard in Metastatic Melanoma? Claus Garbe
11:50:00 Break
11:55:00 Working Lunch Sanjiv S. Agarwala
12:00:00 TBD
13:45:00 Break
13:50:00 Session 9: Enhancing Immune System Surveillance and Response Antoni Ribas
14:00:00 Presession Survey
14:05:00 Anti–CTLA-4 Antibodies and Dialing Down Tolerence Jedd D. Wolchok
14:25:00 Vaccines: Can We Turn the Tide?
14:45:00 Combining Chemotherapy With Immunotherapy: Does It Make Sense? Antoni Ribas
15:05:00 Postsession Survey/Panel Discussion
15:25:00 Presentation of Selected Oral Abstracts
16:00:00 Adjourn
Biotech China 2014
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.